BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11117427)

  • 1. Influence of dose and age on the response of the allopurinol test for ornithine carbamoyltransferase deficiency in control infants.
    Riudor E; Arranz JA; Rodés M; Rubio V; Sentís M; Burlina AB
    J Inherit Metab Dis; 2000 Nov; 23(7):662-8. PubMed ID: 11117427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of allopurinol challenge: sample purification, protein intake control, and the use of orotidine response as a discriminative variable improve performance of the test for diagnosing ornithine carbamoyltransferase deficiency.
    Arranz JA; Riudor E; Rodés M; Roig M; Climent C; Rubio V; Sentís M; Burlina A
    Clin Chem; 1999 Jul; 45(7):995-1001. PubMed ID: 10388475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allopurinol-induced orotidinuria. A test for mutations at the ornithine carbamoyltransferase locus in women.
    Hauser ER; Finkelstein JE; Valle D; Brusilow SW
    N Engl J Med; 1990 Jun; 322(23):1641-5. PubMed ID: 2342523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The allopurinol loading test for identification of carriers for ornithine carbamoyl transferase deficiency: studies in a healthy control population and females at risk.
    Sebesta I; Fairbanks LD; Davies PM; Simmonds HA; Leonard JV
    Clin Chim Acta; 1994 Jan; 224(1):45-54. PubMed ID: 8174277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allopurinol challenge test in children.
    Burlina AB; Ferrari V; Dionisi-Vici C; Bordugo A; Zacchello F; Tuchman M
    J Inherit Metab Dis; 1992; 15(5):707-12. PubMed ID: 1434508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary excretion of orotic acid, orotidine and other pyrimidines in a patient with purine nucleoside phosphorylase deficiency.
    van Gennip AH; Grift J; de Bree PK; Zegers BJ; Stoop JW; Wadman SK
    Clin Chim Acta; 1979 May; 93(3):419-28. PubMed ID: 109238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The urinary excretion of orotic acid and orotidine, measured by an isotope dilution assay.
    Tax WJ; Veerkamp JH; Schretlen ED
    Clin Chim Acta; 1978 Dec; 90(3):217-23. PubMed ID: 365397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The allopurinol loading test in detecting obligate heterozygotes for OCT deficiency.
    Sebesta I; Krijt J; Fairbanks LD; Simmonds HA
    J Inherit Metab Dis; 1994; 17(1):133-4. PubMed ID: 8051924
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful living-donor liver transplantation from an asymptomatic carrier mother in ornithine transcarbamylase deficiency.
    Nagasaka H; Yorifuji T; Egawa H; Kikuta H; Tanaka K; Kobayashi K
    J Pediatr; 2001 Mar; 138(3):432-4. PubMed ID: 11241058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease.
    Bonham JR; Guthrie P; Downing M; Allen JC; Tanner MS; Sharrard M; Rittey C; Land JM; Fensom A; O'Neill D; Duley JA; Fairbanks LD
    J Inherit Metab Dis; 1999 Apr; 22(2):174-84. PubMed ID: 10234613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopurinol-induced pyrimidinuria in cancer patients.
    Carducci MA; Choti M; Maestri NE; Brusilow SW
    In Vivo; 1998; 12(3):271-4. PubMed ID: 9706470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Orotic Aciduria and the Excretion of Orotidine.
    Nyhan WL; Gangoiti JA
    Neuropediatrics; 2016 Dec; 47(6):408-409. PubMed ID: 27574833
    [No Abstract]   [Full Text] [Related]  

  • 13. Benign persistent orotic aciduria and the possibility of misdiagnosis of ornithine carbamoyltransferase deficiency.
    Carpenter KH; Potter M; Hammond JW; Wilcken B
    J Inherit Metab Dis; 1997 Jul; 20(3):354-8. PubMed ID: 9266354
    [No Abstract]   [Full Text] [Related]  

  • 14. How reliable is the allopurinol load in detecting carriers for ornithine transcarbamylase deficiency?
    Grünewald S; Fairbanks L; Genet S; Cranston T; Hüsing J; Leonard JV; Champion MP
    J Inherit Metab Dis; 2004; 27(2):179-86. PubMed ID: 15159648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pitfalls in the detection of heterozygosity by allopurinol in a variant form of ornithine carbamoyltransferase deficiency.
    Barshop BA; Nyhan WL; Climent C; Rubio V
    J Inherit Metab Dis; 2001 Aug; 24(4):513-4. PubMed ID: 11596657
    [No Abstract]   [Full Text] [Related]  

  • 16. Ornithine carbamoyltransferase deficiency: improved sensitivity of testing for protein tolerance in the diagnosis of heterozygotes.
    Potter M; Hammond JW; Sim KG; Green AK; Wilcken B
    J Inherit Metab Dis; 2001 Feb; 24(1):5-14. PubMed ID: 11286382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conditions affecting the colorimetry of orotic acid and orotidine in urine.
    Harris ML; Oberholzer VG
    Clin Chem; 1980 Mar; 26(3):473-9. PubMed ID: 7363468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allopurinol-induced orotidinuria.
    Tuchman M
    N Engl J Med; 1990 Nov; 323(19):1352-3. PubMed ID: 2215627
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of various inhibitors on the regulation of orotic acid excretion in sparse-fur mutant mice (spf/Y) deficient in ornithine transcarbamylase.
    Nelson J; Qureshi IA; Vasudevan S; Sarma DS
    Chem Biol Interact; 1993 Oct; 89(1):35-47. PubMed ID: 8221965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic studies of high doses of allopurinol in humans.
    Nelson DJ; Elion GB
    Adv Exp Med Biol; 1984; 165 Pt A():167-70. PubMed ID: 6720373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.